- Home
- K vs ETON Comparison
K vs ETON Comparison
Compare K & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- K
- ETON
- Stock Information
- Founded
- K 1906
- ETON 2017
- Country
- K United States
- ETON United States
- Employees
- K N/A
- ETON N/A
- Industry
- K Packaged Foods
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- K Consumer Staples
- ETON Health Care
- Exchange
- K Nasdaq
- ETON Nasdaq
- Market Cap
- K 27.8B
- ETON 199.5M
- IPO Year
- K N/A
- ETON 2018
- Fundamental
- Price
- K $80.62
- ETON $12.58
- Analyst Decision
- K Hold
- ETON Strong Buy
- Analyst Count
- K 15
- ETON 2
- Target Price
- K $72.21
- ETON $15.00
- AVG Volume (30 Days)
- K 2.1M
- ETON 235.4K
- Earning Date
- K 02-06-2025
- ETON 11-12-2024
- Dividend Yield
- K 2.83%
- ETON N/A
- EPS Growth
- K 21.82
- ETON N/A
- EPS
- K 2.91
- ETON N/A
- Revenue
- K $12,799,000,000.00
- ETON $34,677,000.00
- Revenue This Year
- K N/A
- ETON $23.05
- Revenue Next Year
- K $2.57
- ETON $81.27
- P/E Ratio
- K $26.92
- ETON N/A
- Revenue Growth
- K 15.11
- ETON 5.64
- 52 Week Low
- K $52.46
- ETON $3.03
- 52 Week High
- K $81.34
- ETON $13.98
- Technical
- Relative Strength Index (RSI)
- K 48.51
- ETON 61.05
- Support Level
- K $80.56
- ETON $11.80
- Resistance Level
- K $80.88
- ETON $13.01
- Average True Range (ATR)
- K 0.27
- ETON 0.70
- MACD
- K -0.03
- ETON -0.14
- Stochastic Oscillator
- K 44.62
- ETON 68.46
About K Kellanova
Following its split from the North American cereal business in October 2023, Kellanova (previously the global snacking arm of Kellogg) has operated as a leading global manufacturer and marketer of salty snacks, snack bars, frozen breakfast fare, meat alternatives, and other packaged foods. Its offerings are manufactured in around 20 countries and marketed in more than 180 countries. Its product mix includes well-known brands such as Pringles, Cheez-It, Rice Krispies Treats, Pop-Tarts, Eggo, Nutri-Grain, and Morningstar Farms. Sales beyond its home turf account for about half of Kellanova's consolidated sales base. Mars is slated to acquire the newly independent business in a nearly $36 billion deal in the first half of calendar 2025.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.